[QT Interval in Patients With COVID-19]
V N Komoliatova1, L M Makarov1
1Center for syncope and cardiac arrhythmias in children and adolescents of the FMBA of Russia. FGBUZ Central Children's Clinical Hospital FMBA of Russia. Department of Pediatrics named after G.N. Speransky RMANPO Ministry of Health of the Russian Federation.
The COVID-19 pandemic poses public health risks. Certain treatments, like azithromycin and hydroxychloroquine, may increase cardiac risks, necessitating careful patient management strategies.
Area of Science:
- Cardiology
- Infectious Diseases
- Pharmacology
Background:
- The emergence of SARS-CoV-2 has led to the COVID-19 pandemic.
- COVID-19 presents a significant global public health challenge.
- Standard treatments for COVID-19 may carry cardiac risks.
Purpose of the Study:
- To review the potential cardiac risks associated with COVID-19 pharmacotherapy.
- To provide recommendations for managing patients during the COVID-19 pandemic.
- To highlight the importance of electrocardiogram monitoring in patients receiving specific COVID-19 treatments.
Main Methods:
- Literature review of existing studies on COVID-19 treatments.
- Analysis of drug information regarding known cardiac side effects.
- Synthesis of clinical recommendations for patient care.
Main Results:
- Azithromycin and hydroxychloroquine can prolong the QT interval.
- QT interval prolongation increases the risk of Torsades de Pointes (a type of pirouette tachycardia).
- This arrhythmia can lead to sudden cardiac death.
Conclusions:
- Careful consideration of cardiac risks is essential when prescribing COVID-19 treatments.
- Patient management should include monitoring for potential drug-induced cardiac events.
- Proactive strategies are needed to mitigate adverse cardiovascular outcomes in COVID-19 patients.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
Correlation between ECG and Cardiac Cycle
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...


